- The European Medicines Agency found a possible link between the Johnson & Johnson COVID-19 vaccine and 'unusual' blood clots cases with low levels of blood platelets.
- The EMA said the link should be listed as "very rare side effects of the vaccine."
- Eight people in the US reported experiencing blood clots after receiving the shot.
- See more stories on Insider's business page.
The European Medicines Agency found a possible link between the Johnson & Johnson COVID-19 vaccine and 'unusual' blood clots cases with low levels of blood platelets, according to a statement issued on Tuesday.
The agency said that the overall benefit-risk remains positive, but said the link should be listed as "very rare side effects of the vaccine." The EMA suggested a warning be attached to product information about the shot.
The US put a pause on the rollout of Johnson & Johnson's single-dose COVID-19 vaccine earlier this month, citing reports of blood clots in people who received the shot.
All of the eight people who have reported blood clots were under 60 years old and the majority of them were women. They all reported the blood clots within three weeks of getting the vaccination.
More than 7.9 million people in the US have gotten the Johnson & Johnson shot, according to the Centers of Disease Control and Prevention.